A-62176, a potent topoisomerase inhibitor, inhibits the expression of human epidermal growth factor receptor 2

Hye Lin Kim, Kyung Hwa Jeon, Kyu Yeon Jun, Yongmun Choi, Dae Kee Kim, Younghwa Na, Youngjoo Kwon

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


HER2 overexpression is observed in ∼6-35% of all gastric cancers, while co-amplification of topoisomerase IIα occurs in ∼32-90% of all cancers with HER2 amplification. The present study reports that HER2 expression is down-regulated by A-62176, a fluoroquinophenoxazine derivative that we previously demonstrated to inhibit topoisomerase I and IIα. The results suggest that A-62176 inhibits the interaction between the ESX, an ets transcription factor, and its co-activator Sur2, leading to the attenuation of HER2-mediated phosphorylation of MAPK/Akt. A-62176 arrests the cell cycle in the G1 phase via the down-regulation of cyclin D1 and the up-regulation of p27Kip1 in NCI-N87 gastric cancer cells. The combination of A-62176 with doxorubicin provides a strong synergistic activity. We propose that A-62176 is a dual inhibitor that impairs the expression of HER2 and restrains the activity of topoisomerase IIα. Our results may lead to the rational design of anticancer molecules targeting a subgroup of gastric cancer cells overexpressing both HER2 and topoisomerase IIα.

Original languageEnglish
Pages (from-to)72-79
Number of pages8
JournalCancer Letters
Issue number1
StatePublished - 1 Dec 2012

Bibliographical note

Funding Information:
This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0071926, 2009-0066925, 2010-0002646) and by the Ewha Global Top5 Grant 2011 of Ewha Womans University.


  • Fluoroquinophenoxazine derivative
  • Gastric cancer
  • Human epidermal growth factor receptor 2
  • Topoisomerase IIα


Dive into the research topics of 'A-62176, a potent topoisomerase inhibitor, inhibits the expression of human epidermal growth factor receptor 2'. Together they form a unique fingerprint.

Cite this